Bronchiectasis in renal transplant patients: a narrative review
Abstract
Non-cystic fibrosis bronchiectasis is associated with many causes including post-infectious damage, immunodeficiency, connective tissue disease and ciliary dysfunction and can also overlap with chronic obstructive pulmonary disease and asthma. Renal transplantation (RT) is the most common solid-organ transplantation worldwide. Since 2004, bronchiectasis associated with RT has been described in case reports and series involving children and adult patients. The pathogenesis remains unclear and may combine underlying renal diseases, immunodeficiency, direct toxicity of immunosuppressive drugs and lower tract infections. This narrative review, supported by the extensive literature in PubMed, Cochrane Library and Web of Science, provides a state-of-the-art of current knowledge regarding the epidemiology, pathophysiology and clinical impact of bronchiectasis in renal transplant patients. Finally, we provide management proposals for RT-associated bronchiectasis in clinical practice.
Related
- Central Nervous System Toxoplasmosis Beyond HIV in Patients with Hematologic Malignancies: A Contemporary Narrative Review and Illustrative Case Synthesis
- Mixed infection with multiple bacteria and microsporidia (Enterocytozoon bieneusi) in a post-renal transplant patient: a case report.
- Responsible use of new antibiotics for critically ill patients suffering from infections due to carbapenem-resistant organisms—a narrative review for an enablement strategy
- Broad-Range PCR-Electrospray Ionization Mass Spectrometry for Detection and Typing of Adenovirus and Other Opportunistic Viruses in Stem Cell Transplant Patients
- Kinetics of early immune reconstitution and its exploratory association with post-transplant outcomes in patients undergoing haploidentical HCT with post-transplant cyclophosphamide-based GvHD prophylaxis
BibTeX
@article{dury2026bronchiectasis,
title = {{Bronchiectasis in renal transplant patients: a narrative review}},
author = {Sandra Dury and Julien Ancel and Pauline Mulette and Julie Malet and Alexandre Vivien and Valerian Dormoy and Thomas Guillard and Anaëlle Muggeo and Vincent Vuiblet and Charlotte Colosio and Claire Launois and Jeanne-Marie Perotin and Gaëtan Deslee},
journal = {BMJ open respiratory research},
year = {2026},
month = jul,
doi = {10.1136/bmjresp-2026-004247},
url = {https://univ-reims.hal.science/hal-05735440v1},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Bronchiectasis in renal transplant patients: a narrative review
AU - Sandra Dury
AU - Julien Ancel
AU - Pauline Mulette
AU - Julie Malet
AU - Alexandre Vivien
AU - Valerian Dormoy
AU - Thomas Guillard
AU - Anaëlle Muggeo
AU - Vincent Vuiblet
AU - Charlotte Colosio
AU - Claire Launois
AU - Jeanne-Marie Perotin
AU - Gaëtan Deslee
PY - 2026
DA - 2026/07/21
JO - BMJ open respiratory research
DO - 10.1136/bmjresp-2026-004247
UR - https://univ-reims.hal.science/hal-05735440v1
AB - Non-cystic fibrosis bronchiectasis is associated with many causes including post-infectious damage, immunodeficiency, connective tissue disease and ciliary dysfunction and can also overlap with chronic obstructive pulmonary disease and asthma. Renal transplantation (RT) is the most common solid-organ transplantation worldwide. Since 2004, bronchiectasis associated with RT has been described in case reports and series involving children and adult patients. The pathogenesis remains unclear and may combine underlying renal diseases, immunodeficiency, direct toxicity of immunosuppressive drugs and lower tract infections. This narrative review, supported by the extensive literature in PubMed, Cochrane Library and Web of Science, provides a state-of-the-art of current knowledge regarding the epidemiology, pathophysiology and clinical impact of bronchiectasis in renal transplant patients. Finally, we provide management proposals for RT-associated bronchiectasis in clinical practice.
SN - 2052-4439
ER -